Samrat Pharmachem Ltd. Schedules Board Meeting to Review FY26 Financial Results
Samrat Pharmachem Limited announced that a board meeting will be held on May 30, 2026, to review and approve the Audited Standalone Financial Results for the financial year ended March 31, 2026, prepared under Indian Accounting Standards (Ind-As). The meeting will also include a review of the audit reports from the statutory auditor.The company will release the audited financial results after the board meeting concludes and will disseminate them through press releases and its website, www.samratpharmachem.com. The meeting is scheduled to begin at 2:00 P.M. at the corporate office located at 701/702, Business Square, M. A. Road, Andheri (West), Mumbai - 400 058.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.